Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 28;13(1):61.
doi: 10.3390/jpm13010061.

Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis

Luis Sainz  1   2   3 , Pau Riera  3   4   5 , Patricia Moya  1   3 , Sara Bernal  3   5   6 , Jordi Casademont  2   3   7 , Cesar Díaz-Torné  1   2   3 , Ana Milena Millán  1   3 , Hye Sang Park  1   3 , Adriana Lasa  3   5   6 , Héctor Corominas  1   2   3
Affiliations

Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis

Luis Sainz et al. J Pers Med. .

Abstract

Tocilizumab is a first-line biologic disease-modifying anti-rheumatic drug (bDMARD) that inhibits the interleukin-6 (IL-6) pathway by antagonizing the IL-6 receptor (IL-6R). Tocilizumab is widely used to treat rheumatoid arthritis (RA), a prevalent autoimmune disease that can cause irreversible joint damage and disability. Although many bDMARDs have been developed for RA, there is a lack of validated biomarkers which could guide personalized medicine strategies. To evaluate whether single-nucleotide polymorphisms (SNPs) in the IL6R gene could predict tocilizumab toxicity in patients with RA, we conducted a retrospective cohort study of 88 patients treated with tocilizumab. Six SNPs previously described in the IL6R gene were genotyped (rs12083537, rs11265618, rs4329505, rs2228145, rs4537545, and rs4845625). Using parametric tests, we studied the association between the SNPs and hepatotoxicity, infection, hypersensitivity, gastrointestinal, hematological, and dyslipidemia adverse events (AEs). We found associations between dyslipidemia and rs4845625 and between hematological AEs and rs11265618 and rs4329505. No further associations were found for the remaining SNPs and other AEs. Our findings support the potential clinical value of SNPs in the IL6R gene as predictive biomarkers for toxicity to tocilizumab in patients with RA.

Keywords: IL6R; genetic variants; predictive biomarkers; rheumatoid arthritis; tocilizumab; toxicity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Seoane-Mato D., Sánchez-Piedra C., Silva-Fernández L., Sivera F., Blanco F.J., Ruiz F.P., Juan-Mas A., Pego-Reigosa J.M., Narváez J., Martí N.Q., et al. Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims and methodology. Reumatol. Clin. 2015;15:90–96. doi: 10.1016/j.reuma.2017.06.009. - DOI - PubMed
    1. Cross M., Smith E., Hoy D., Carmona L., Wolfe F., Vos T., Williams B., Gabriel S., Lassere M., Johns N., et al. The global burden of rheumatoid arthritis: Estimates from the Global Burden of Disease 2010 study. Ann. Rheum. Dis. 2014;73:1316–1322. doi: 10.1136/annrheumdis-2013-204627. - DOI - PubMed
    1. McInnes I.B., Schett G. The Pathogenesis of Rheumatoid Arthritis. N. Engl. J. Med. 2011;365:2205–2219. doi: 10.1056/NEJMra1004965. - DOI - PubMed
    1. Rodríguez-Valverde V., Cáliz R.C., Álvaro J.M.-G., de la Fuente J.L.M., Mendoza J.M., Molina J.T., Sánchez J.A., García F.B., Gualda E.B., Crespillo J.C., et al. III Actualización del Consenso de la Sociedad Española de Reumatología sobre terapia biológica en la artritis reumatoide. Reumatol. Clin. 2006;2((Suppl. S2)):S52–S59. doi: 10.1016/S1699-258X(06)73097-2. - DOI - PubMed
    1. Goekoop-Ruiterman Y.P., De Vries-Bouwstra J.K., Allaart C.F., Van Zeben D., Kerstens P.J., Hazes J.M.W., Zwinderman A.H., Peeters A.J., De Jonge-Bok J.M., Mallée C., et al. Comparison of Treatment Strategies in Early Rheumatoid Arthritis: A randomized trial. Ann. Intern. Med. 2007;146:406–415. doi: 10.7326/0003-4819-146-6-200703200-00005. - DOI - PubMed